Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression

被引:104
作者
Gaudieri, S
DeSantis, D
McKinnon, E
Moore, C
Nolan, D
Witt, CS
Mallal, SA
Christiansen, FT
机构
[1] Royal Perth Hosp, Ctr Clin Immunol & Biochem Genet, Dept Clin Immunol & Biochem Genet, Perth, WA 6000, Australia
[2] Murdoch Univ, Ctr Clin Immunol & Biomed Stat, Murdoch, WA 6150, Australia
[3] Univ Western Australia, Sch Anat & Human Biol, Ctr Forens Sci, Nedlands, WA 6009, Australia
[4] Univ Western Australia, Sch Surg & Pathol, Nedlands, WA 6009, Australia
基金
英国医学研究理事会;
关键词
NK cells; HLA; AIDS; killer immunoglobulin-like receptors;
D O I
10.1038/sj.gene.6364256
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Variation in the host response to infection by pathogens including HIV-1 may be conferred by polymorphic genetic factors such as HLA and killer immunoglobulin-like receptors (KIR) genes. Here, we examined KIR and HLA genotype effects on pretreatment viral load, rate of CD4(+) T-cell decline and progression to AIDS among adult HIV-1-infected patients within the Western Australian HIV Study Cohort. In this study, carriage of KIR genes within the 'B' haplotype (eg KIR2DS2) was specifically associated with a more rapid CD4(+) T-cell decline over time and progression to AIDS. In contrast, KIR gene repertoire had no effect on pretreatment viral load while selected HLA alleles ( eg HLA-B* 5701, HLA-B* 2705) demonstrated significant protective effects on viremia. Furthermore, interactions between specific HLA and KIR genes did appear to influence HIV disease progression. The results suggest that host genetic variation within the HLA and KIR gene complexes have clinically relevant effects on the course of HIV-1/AIDS, acting independently as well as synergistically to modify disease progression at multiple levels.
引用
收藏
页码:683 / 690
页数:8
相关论文
共 41 条
[1]   Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules [J].
Bonaparte, MI ;
Barker, E .
BLOOD, 2004, 104 (07) :2087-2094
[2]   Considering genetic profiles in functional studies of immune responsiveness to HIV-1 [J].
Carrington, M ;
Nelson, G ;
O'Brien, SJ .
IMMUNOLOGY LETTERS, 2001, 79 (1-2) :131-140
[3]  
CAVALLISFORZA LL, 1971, GENETICS HUMAN POPUL
[4]   Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection [J].
Chouquet, C ;
Autran, B ;
Gomard, E ;
Bouley, JM ;
Calvez, V ;
Katlama, C ;
Costagliola, D ;
Rivière, Y .
AIDS, 2002, 16 (18) :2399-2407
[5]   The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells [J].
Cohen, GB ;
Gandhi, RT ;
Davis, DM ;
Mandelboim, O ;
Chen, BK ;
Strominger, JL ;
Baltimore, D .
IMMUNITY, 1999, 10 (06) :661-671
[6]   HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes [J].
Collins, KL ;
Chen, BK ;
Kalams, SA ;
Walker, BD ;
Baltimore, D .
NATURE, 1998, 391 (6665) :397-401
[7]   Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease [J].
Dawkins, R ;
Leelayuwat, C ;
Gaudieri, S ;
Tay, G ;
Hui, J ;
Cattley, S ;
Martinez, P ;
Kulski, J .
IMMUNOLOGICAL REVIEWS, 1999, 167 :275-304
[8]   Associations of MHC ancestral haplotypes,with resistance/susceptibility to AIDS disease development [J].
Flores-Villanueva, PO ;
Hendel, H ;
Caillat-Zucman, S ;
Rappaport, J ;
Burgos-Tiburcio, A ;
Bertin-Maghit, S ;
Ruiz-Morales, JA ;
Teran, ME ;
Rodriguez-Tafur, J ;
Zagury, JF .
JOURNAL OF IMMUNOLOGY, 2003, 170 (04) :1925-1929
[9]   Human KIR sequences 2003 [J].
Garcia, CA ;
Robinson, J ;
Guethlein, LA ;
Parham, P ;
Madrigal, JA ;
Marsh, SGE .
IMMUNOGENETICS, 2003, 55 (04) :227-239
[10]   Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses [J].
Gaudieri, S ;
Nolan, D ;
McKinnon, E ;
Witt, CS ;
Mallal, S ;
Christiansen, FT .
MOLECULAR IMMUNOLOGY, 2005, 42 (04) :557-560